Cat.#: ACPP-1278
| Despition | EAAT1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1474 | Human RGS21 Protein (AC1474) | 5 µg | inquiry |
| ACPP-1734 | Human EFNA3 Protein (AC1734) | 5 µg | inquiry |
| ACPP-1149 | Recombinant Human TNF Receptor II Protein (Fc Tag) (AC1149) | 50 µg | inquiry |
| ACPP-1537 | Human YY1 Protein (AC1537) | 5 µg | inquiry |
| ACPP-1343 | GIRK1 Blocking Peptide (AC1343) | 250 µg | inquiry |
| ACPP-1678 | Human SDCBP Protein (AC1678) | 5 µg | inquiry |
| ACPP-1054 | Recombinant Human Neuroglycan C Protein (6×His Tag) (AC1054) | 50 µg | inquiry |
| ACPP-1422 | Human CKB Protein, Pichia (AC1422) | 10 µg | inquiry |
| ACPP-1837 | Rat SCGN Protein (AC1837) | 2 µg | inquiry |
| ACPP-1203 | ADCY8 Blocking Peptide (AC1203) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.